1. 287 Safety and antitumor activity of indoleamine 2, 3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors. (10th December 2020) Authors: Sahebjam, Solmaz; Muzaffar, Jameel; Yap, Timothy; Hong, David; Rixe, Olivier; Brown-Glaberman, Ursa; Varga, Andreea; Massard, Christophe; Baldini, Capucine; Efuni, Sergey; Kapelan, Barbara; Liu, Yi; Ogunmefun, Eniola; Tayama, Tomonori; Zhao, Henry; Healy, Denis; Latek, Robert; Nakashima, Daisuke;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 287 Safety and antitumor activity of indoleamine 2, 3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors. (9th November 2020) Authors: Sahebjam, Solmaz; Muzaffar, Jameel; Yap, Timothy; Hong, David; Rixe, Olivier; Brown-Glaberman, Ursa; Varga, Andreea; Massard, Christophe; Baldini, Capucine; Efuni, Sergey; Kapelan, Barbara; Liu, Yi; Ogunmefun, Eniola; Tayama, Tomonori; Zhao, Henry; Healy, Denis; Latek, Robert; Nakashima, Daisuke;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗